Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H ten Have

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
European Journal of Endocrinology|March 5, 2005
The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrationsIngrid E Bonapart, Ron van Domburg, Saskia M T H ten Have, et al.
Lancet (London, England)|May 12, 2005
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegalyJ Feenstra, W W de Herder, S M T H ten Have, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
European Journal of Endocrinology|March 5, 2005
The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrationsIngrid E Bonapart, Ron van Domburg, Saskia M T H ten Have, et al.
Lancet (London, England)|May 12, 2005
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegalyJ Feenstra, W W de Herder, S M T H ten Have, et al.
Pageof 4